{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:01:27Z","timestamp":1781157687493,"version":"3.54.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Standard treatments for pediatric acute gastroenteritis (AGE) have critical limitations in symptom control and medication adherence among young children. This study evaluated the efficacy and safety of Erxiekang Emplastra as adjunctive therapy for AGE in children aged 1 to 14 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective cohort study reviewed electronic medical records of children hospitalized with AGE between January 2024 and March 2025. Eligible patients were categorized into an exposed group receiving Erxiekang Emplastra plus standard therapy and an unexposed group receiving standard therapy alone. The primary outcome was diarrhea duration; secondary outcomes included the 3-day Modified Vesikari Scale (MVS) and treatment-related adverse events. Multivariable linear regression was conducted to quantify the independent therapeutic benefits of the Erxiekang Emplastra.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1,089 eligible patients were included, with 417 in the exposed group and 672 in the unexposed group. The exposed group had significantly shorter diarrhea duration (3.83 vs. 4.92 days,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.01) and lower 3-day MVS (2.90 vs. 4.51,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.01). Adjunctive Erxiekang Emplastra was independently associated with reduced diarrhea duration (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u2009\u20130.38,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.01; R\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.19) and lower 3-day MVS (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u2009\u20130.44,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.01; R\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.22). Only 1.44% of patients developed mild transient local reactions, with no severe adverse events reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Erxiekang Emplastra showed favorable tolerability in this pediatric AGE cohort, and its adjunctive use was independently associated with shortened diarrhea duration and reduced disease severity. Large-scale, multicenter, prospective randomized controlled trials are warranted to confirm the efficacy and safety of this intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1832504","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:48:19Z","timestamp":1781156899000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Erxiekang emplastra as adjunctive therapy for acute gastroenteritis in children: a single-center retrospective cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Cuiyun","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Nursing, Liyang People\u2019s Hospital","place":["Liyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Nursing, Liyang People\u2019s Hospital","place":["Liyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongli","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Liyang People\u2019s Hospital","place":["Liyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Liyang People\u2019s Hospital","place":["Liyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Liyang People\u2019s Hospital","place":["Liyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40249-016-0157-2","article-title":"Impact of co-infections with enteric pathogens on children suffering from acute diarrhea in southwest China","volume":"5","author":"Zhang","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"B2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1590\/0074-02760140381","article-title":"The prevalence of norovirus, astrovirus and adenovirus infections among hospitalised children with acute gastroenteritis in porto velho, state of rond\u00f4nia, western Brazilian Amazon","volume":"110","author":"Amaral","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e068319","DOI":"10.1136\/bmjopen-2022-068319","article-title":"Prevalence and associated factors of acute gastroenteritis in children and adolescents aged from 6 to 17 years old: a cross-sectional study based on the national health and nutrition examination survey database 1999-2018","volume":"13","author":"Cai","year":"2023","journal-title":"BMJ Open"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e72788","DOI":"10.1371\/journal.pone.0072788","article-title":"Global causes of diarrheal disease mortality in children <5 years of age: a systematic review","volume":"8","author":"Lanata","year":"2013","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0151219","DOI":"10.1371\/journal.pone.0151219","article-title":"Global economic burden of norovirus gastroenteritis","volume":"11","author":"Bartsch","year":"2016","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3201\/eid3005.230356","article-title":"Economic burden of acute gastroenteritis among members of integrated healthcare delivery system, United States, 2014\u22122016","volume":"30","author":"Dickerson","year":"2024","journal-title":"Emerg Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/mpg.0000000000000375","article-title":"European Society for pediatric gastroenterology, hepatology, and nutrition\/European society for pediatric infectious diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014","volume":"59","author":"Guarino","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/archdischild-2023-326449","article-title":"Rehydration strategies in infants and children with acute gastroenteritis refusing or not tolerating an oral fluid challenge","volume":"109","author":"Clay","year":"2024","journal-title":"Arch Dis Child"},{"key":"B9","doi-asserted-by":"publisher","first-page":"123834","DOI":"10.1016\/j.ijpharm.2024.123834","article-title":"Umbilical therapy for promoting transdermal delivery of topical formulations: enhanced effect and underlying mechanism","volume":"652","author":"Yang","year":"2024","journal-title":"Int J Pharm"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.3390\/molecules24193473","article-title":"Cinnamomum cassia presl: a review of its traditional uses, phytochemistry, pharmacology and toxicology","volume":"24","author":"Zhang","year":"2019","journal-title":"Molecules"},{"key":"B11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1542\/hpeds.2023-007357","article-title":"Evaluating acute viral gastroenteritis severity: modified vesikari and clark scoring systems","volume":"14","author":"Plancarte","year":"2024","journal-title":"Hosp Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0140-6736(18)31128-0","article-title":"Viral gastroenteritis","volume":"392","author":"B\u00e1nyai","year":"2018","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3238\/arztebl.2020.0615","article-title":"Acute infectious gastroenteritis in infancy and childhood","volume":"117","author":"Posovszky","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.biopha.2018.12.033","article-title":"Evodiamine prevents dextran sulfate sodium-induced murine experimental colitis via the regulation of nf-\u039ab and Nlrp3 inflammasome","volume":"110","author":"Shen","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10506","DOI":"10.1021\/acs.jafc.1c00917","article-title":"Eugenol alleviates dextran sulfate sodium-induced colitis independent of intestinal microbiota in mice","volume":"69","author":"Chen","year":"2021","journal-title":"J Agric Food Chem"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.3390\/ijms23115889","article-title":"Anti-inflammatory mechanism of an alkaloid rutaecarpine in lta-stimulated raw 264.7 cells: pivotal role on nf-\u039ab and erk\/P38 signaling molecules","volume":"23","author":"Jayakumar","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1039\/d2fo01835g","article-title":"Cinnamon (Cinnamomum cassia) water extract improves diarrhea symptoms by changing the gut environment: a randomized controlled trial","volume":"14","author":"Park","year":"2023","journal-title":"Food Funct"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s43088-022-00196-1","article-title":"Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials","volume":"11","author":"Tripathi","year":"2022","journal-title":"Beni Suef Univ J Basic Appl Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/mpg.0000000000002904","article-title":"Factors associated with nonadherence in an emergency department-based multicenter randomized clinical trial of a probiotic in children with acute gastroenteritis","volume":"72","author":"Schnadower","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e20170062","DOI":"10.1542\/peds.2017-0062","article-title":"Herbal medicines for gastrointestinal disorders in children and adolescents: a systematic review","volume":"139","author":"Anheyer","year":"2017","journal-title":"Pediatrics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/jpids\/piae090","article-title":"Evaluation of a modified vesikari severity score as a research tool for assessing pediatric acute gastroenteritis","volume":"13","author":"Wikswo","year":"2024","journal-title":"J Pediatr Infect Dis Soc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.3390\/v15112185","article-title":"Norovirus-associated gastroenteritis vesikari score and pre-existing salivary iga in young children from rural South Africa","volume":"15","author":"Kabue","year":"2023","journal-title":"Viruses"},{"key":"B23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/s12889-020-08595-8","article-title":"Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates","volume":"20","author":"Baral","year":"2020","journal-title":"BMC Public Health"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1832504\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:48:20Z","timestamp":1781156900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1832504\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":23,"alternative-id":["10.3389\/fped.2026.1832504"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1832504","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"article-number":"1832504"}}